OMG - a post from NSB just now . They are alive , call back the search party
- Forums
- ASX - By Stock
- NSB
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts, page-2
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.494M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 54000 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 179255 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 54000 | 0.034 |
3 | 160000 | 0.033 |
1 | 200000 | 0.032 |
1 | 500000 | 0.031 |
3 | 562332 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 179255 | 2 |
0.041 | 200000 | 1 |
0.043 | 40000 | 1 |
0.045 | 45000 | 2 |
0.046 | 50000 | 1 |
Last trade - 16.12pm 13/09/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
Day chart unavailable
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online
Glaucoma is characterised by the degeneration of retinal ganglion cells and retinal nerve fiber layers that result in changes in the optical nerve head, which end up affecting vision and can progress to full visual loss.NeuroScientific Biopharmaceuticals Ltd is focused on developing #EmtinB as a much needed neuroprotective and possibly neuroregenerative product for #glaucoma that will hopefully prevent, slow down and possibly reverse vision loss in glaucoma patients, which is expected to affect as many as 112 million people worldwide by 2040.